MTVA
MetaVia Inc.
Key Financials
EPS (Diluted)
$-7.35
↓ 106.5%
Operating Income
$-13708000
↑ 52.4%
Total Liabilities
$5.8M
↓ 30.5%
Total Assets
$11.1M
↓ 31.6%
Shareholders' Equity
$5.3M
↓ 32.8%
Cash & Equivalents
$10.3M
↓ 35.8%
Operating Cash Flow
$-15701000.00
↑ 36.5%
Net Income
$-12973000
↑ 53.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 7/2/2026 | View on SEC |
| 424B5 | 7/2/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| S-8 | 6/8/2026 | View on SEC |
| 8-K | 6/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | MTVA |
| Company Name | MetaVia Inc. |
| CIK | 1638287 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (857) 702-9600 |